Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features
Depression is the leading cause of suicide, and antidepressants and modified electroconvulsive therapy (mECT) are the preferred treatment modalities. Ketamine is an established anesthetic agent and evidence for its use in depression is evolving. Here, we discuss the experience of treating severe dep...
Saved in:
Main Authors: | T. V. Pavan Kumar, Divya Bolla, Raj Kiran Donthu, Anzory Pathak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Annals of Indian Psychiatry |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/aip.aip_212_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
by: Katelyn Halpape, et al.
Published: (2025-01-01) -
Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?
by: Monika Makar, et al.
Published: (2025-01-01) -
A Comparative Study on the Effectiveness of Electroconvulsive Therapy and Ketamine in Persons Suffering from Treatment-resistant Depressive Disorder
by: Vikhram Ramasubramanian, et al.
Published: (2024-12-01) -
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
by: Moaz Yasser Darwish, et al.
Published: (2025-02-01) -
Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
by: Thuy-Dung Nguyen, et al.
Published: (2025-02-01)